FDA
-
-
-
-
-
-
-
Neurotrope (NTRP), Worldwide Clinical Trials Report Agreement to Conduct Ongoing Phase 2 Study of Bryostatin-1, Partially Funded by NIH, for Alzheimer's Disease
-
-
-
-
-
-
-
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial
-
-
-
-
-
-
-
Neurotrope Announces Corporate Update and Reports Second Quarter 2019 Financial Results
-
-
-
-
-
-
-
Neurotrope to Present at the LD Micro 9th Annual Invitational Conference on June 4, 2019
-
-
-
-
-
-
-
Neurotrope Reports Year End 2018 Financial Results
-
-
-
-
-
-
-
Neurotrope Announces the Appointment of Two New Board Members
-
-
-
-
-
-
-
Neurotrope (NTRP) Announces Pact with Nemours / Alfred I. duPont Hospital for Children to Commence Clinical Trial in Fragile X
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

